Pharma Pulse 12/19/24: The Path Forward for Infused Biosimilars in the US, Preventing Antimicrobial Resistance & more

The Path Forward for Infused Biosimilars in the US

In this exclusive PC Podcast interview, Vibhu Tewary, project director, IQVIA Institute for Human Data Science, offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.

Pharmacists Play a Critical Role in Preventing Antimicrobial Resistance

Promoting antimicrobial stewardship and providing patient education are examples of strategies to prevent antimicrobial resistance.

Merck Snags Chinese Obesity Drug in Nearly $2 Billion Deal

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.

Wisp Partners with Nourish to Offer Patients on GLP-1s Personalized Nutrition Counseling

Wisp announced a strategic partnership with Nourish. Wisp patients can now access nutrition counseling services either through their health insurance or an exclusive self-pay rate, making it easier for women seeking a more holistic approach to weight management to access high-quality nutrition support at an affordable price.

Precision For Medicine on LinkedIn

Our CEO, Margaret Keegan, is featured in the December issue of Pharmaceutical Executive candidly discussing the future of clinical development, the changing commercialization sector and the manufacturing of tomorrow’s medicines.

The article also highlights what is possible now with AI and how Precision is helping navigate biotechnology and pharmaceutical companies into the next era of healthcare:

https://lnkd.in/eSF4Dx5C

#clinical #manufacturing #research #biotechnology #pharmaceutical #drugspharmaceuticals #health #healthcare #womeninscience #science

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs